ATPase level in Iraqi Diabetic Patients with and without Diabetic Kidney Disease

被引:0
作者
Ibrahim, Reham khuldon [1 ]
Ghudhaib, Kadhim K. [2 ]
Allawi, Ali Abdulmajid Dyab [3 ]
机构
[1] Alshaab Univ, Coll Engn & Informat Technol, Dept Med Instrument Tech Engn, Baghdad, Iraq
[2] Univ Baghdad, Coll Sci Women, Dept Chem, Baghdad, Iraq
[3] Univ Baghdad, Coll Med, Dept Med, Baghdad, Iraq
关键词
ATPase; Albumin to creatinine ratio; Diabetes mellitus; Diabetic nephropathy; Estimation glomerular filtration rate; SYSTEM; GENDER;
D O I
10.21123/2411-7986.4952
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Complications of diabetes have become one of the main problems that diabetics suffer from, especially during long periods. One of these complications is diabetic nephropathy, as both glomeruli and tubules are exposed to fibrosis due to diabetes. Recent years have witnessed great interest by researchers regarding diabetic nephropathy. This study aimed to determine the level of ATPase and some of the relevant biochemical factors in patients with diabetes and diabetic nephropathy compared with healthy controls. The study included 120 male and female (60 male and 60 female) ranging in age (30-65) years old. Ninety patients with type 2 diabetes are subdivided into three groups on the basis of ACR criteria including normoalbuminuria, microalbuminuria, macroalbuminuria (30 patients for each group). A control group of 30 healthy people was included. This study was conducted at Baghdad Teaching Hospital / Medical City and Al-Yarmouk Teaching Hospital during the period between December 2021 and May 2022 ATPase levels were determined using the ELISA technique, and HbA1c was assessed using the I-chroma device. ATPase levels were found to be significantly increased in patient groups than in healthy control. On the basis of the obtained results in this study, we can be concluded that Na-K ATPase can be applied as a reliable prognosticated factor between disease and normal cases. Furthermore, area under the curve (ROC) analysis data revealed that ATPase was found to be a perfect marker for follow-up diabetic nephropathy disease.
引用
收藏
页数:8
相关论文
共 27 条
[1]   Gender and the renal nitric oxide synthase system in healthy humans [J].
Ahmed, Sofia B. ;
Fisher, Naomi D. L. ;
Hollenberg, Norman K. .
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 2 (05) :926-931
[2]   High Sensitive C Reactive Protein as Predictor Marker for Cardiovascular Diseases in Sudanese Type 2 Diabetic Patients [J].
Aijack, Hala Abdalazeem ;
Edris, Omer Fadul ;
Ismail, Amar Mohamed .
SUDAN JOURNAL OF MEDICAL SCIENCES, 2019, 14 (03) :132-142
[3]   Milk Tumor Necrosis Factor Alpha and Interleukin-1Beta Among Toxoplasma gondii-Free and Infected Women [J].
Al-Hassnawi, Alaa Tareq Shakir ;
Al-Morshidy, Kassim Abdulla Hamza ;
Al-Harbi, Nuha Yaarub .
BAGHDAD SCIENCE JOURNAL, 2022, 19 (01) :1-6
[4]  
[Anonymous], 1982, J Natl Med Assoc, V74, P43
[5]   Conformational states of the pig kidney Na+/K+-ATPase differently affect bufadienolides and cardenolides: A directed structure-activity and structure-kinetics study [J].
Azalim, Pedro ;
do Monte, Fernando M. ;
Rendeiro, Mariana Manzano ;
Liu, Xiaofan ;
O'Doherty, George A. ;
Fontes, Carlos Frederico ;
Leitao, Suzana Guimaraes ;
Quintas, Luis Eduardo M. ;
Noel, Francois .
BIOCHEMICAL PHARMACOLOGY, 2020, 171
[6]   Mineralocorticoid receptor antagonists in diabetic kidney disease - mechanistic and therapeutic effects [J].
Barrera-Chimal, Jonatan ;
Lima-Posada, Ixchel ;
Bakris, George L. ;
Jaisser, Frederic .
NATURE REVIEWS NEPHROLOGY, 2022, 18 (01) :56-70
[7]   Nitric oxide signalling in kidney regulation and cardiometabolic health [J].
Carlstrom, Mattias .
NATURE REVIEWS NEPHROLOGY, 2021, 17 (09) :575-590
[8]   Improving the residual risk of renal and cardiovascular outcomes in diabetic kidney disease: A review of pathophysiology, mechanisms, and evidence from recent trials [J].
Chaudhuri, Ajay ;
Ghanim, Husam ;
Arora, Pradeep .
DIABETES OBESITY & METABOLISM, 2022, 24 (03) :365-376
[9]   Modifying chronic kidney disease progression with the mineralocorticoid receptor antagonist finerenone in patients with type 2 diabetes [J].
DeFronzo, Ralph A. ;
Bakris, George L. .
DIABETES OBESITY & METABOLISM, 2022, 24 (07) :1197-1205
[10]  
Ghudhaib KK, 2014, IOSR J Appl Chem, V7, P119, DOI [10.9790/5736-0752119122, DOI 10.9790/5736-0752119122]